These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20587399)

  • 1. Extreme hyperkalaemia caused by concomitant use of a NSAID and an ace inhibitor in an elderly patient.
    Rogulj D; Hauptfeld M; Iskra MS; Zorko VK; Strasek M
    Arh Hig Rada Toksikol; 2010 Jun; 61(2):241-5. PubMed ID: 20587399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study.
    Fournier JP; Lapeyre-Mestre M; Sommet A; Dupouy J; Poutrain JC; Montastruc JL
    PLoS One; 2012; 7(3):e34187. PubMed ID: 22479557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperkalaemic quadriparesis secondary to chronic diclofenac treatment.
    Patel P; Mandal B; Greenway MW
    Postgrad Med J; 2001 Jan; 77(903):50-1. PubMed ID: 11123398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperkalemias].
    Radó J; Haris A
    Orv Hetil; 1999 Nov; 140(47):2611-8. PubMed ID: 10613044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electrolyte abnormalities and metabolic acidosis in two Duchenne muscular dystrophy patients with advanced congestive heart failure].
    Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
    Rinsho Shinkeigaku; 2000 May; 40(5):439-45. PubMed ID: 11002725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients.
    Indermitte J; Burkolter S; Drewe J; Krähenbühl S; Hersberger KE
    Drug Saf; 2007; 30(1):71-80. PubMed ID: 17194172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which drugs affect potassium?
    Howes LG
    Drug Saf; 1995 Apr; 12(4):240-4. PubMed ID: 7646822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs.
    Bugge JF
    J Intern Med; 1996 Oct; 240(4):249-51. PubMed ID: 8918517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal hyperkalemia related to combined therapy with a COX-2 inhibitor, ACE inhibitor and potassium rich diet.
    Hay E; Derazon H; Bukish N; Katz L; Kruglyakov I; Armoni M
    J Emerg Med; 2002 May; 22(4):349-52. PubMed ID: 12113843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent severe angioedema associated with imidapril and diclofenac.
    Kampitak T
    Allergol Int; 2008 Dec; 57(4):441-3. PubMed ID: 18946239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of the concomitant use of angiotensin-converting enzyme inhibitors, non-steroidal anti-inflammatory drugs and diuretics.
    Bucsa C; Moga DC; Farcas A; Mogosan C; Dumitrascu DL
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2938-44. PubMed ID: 26241552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syncope caused by nonsteroidal anti-inflammatory drugs and angiotensin-converting enzyme inhibitors.
    Kurata C; Uehara A; Sugi T; Yamazaki K
    Jpn Circ J; 1999 Dec; 63(12):1002-3. PubMed ID: 10614849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life threatening hyperkalaemia with diarrhoea during ACE inhibition.
    McGuigan J; Robertson S; Isles C
    Emerg Med J; 2005 Feb; 22(2):154-5. PubMed ID: 15662077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction.
    Ray K; Dorman S; Watson R
    J Hum Hypertens; 1999 Oct; 13(10):717-20. PubMed ID: 10516744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening hyperkalaemia caused by ACE inhibitor and diuretics.
    Jarman PR; Keheley AM; Mather HM
    Diabet Med; 1997 Sep; 14(9):808. PubMed ID: 9300234
    [No Abstract]   [Full Text] [Related]  

  • 16. [Malignant arrhythmias caused by hyperkalemia: a new area of drug-induced electrolyte abnormalities].
    Tomcsányi J; Somlói M; Arabadzisz H; Horváth L
    Orv Hetil; 2002 Mar; 143(13):663-6. PubMed ID: 11975043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity in the elderly due to co-prescription of ACE inhibitors and NSAIDs.
    Jolobe OM
    J R Soc Med; 2001 Dec; 94(12):657-8. PubMed ID: 11733607
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity associated with concomitant ACE inhibitor and NSAID therapy.
    Seelig CB; Maloley PA; Campbell JR
    South Med J; 1990 Oct; 83(10):1144-8. PubMed ID: 2218652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diclofenac induced renal dysfunction presenting as cardiac arrhythmia.
    Alva JP; Kotian G
    J Assoc Physicians India; 2001 Jul; 49():749-52. PubMed ID: 11573564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.